News

Aclarion Welcomes Greg Gould as New CFO to Accelerate Growth

Aclarion Welcomes Greg Gould as New CFO to Accelerate Growth

Aclarion Enhances Leadership with CFO Appointment

Aclarion, Inc., a prominent healthcare technology firm, has announced the appointment of Greg Gould as its Chief Financial Officer (CFO). With over 30 years of both public and private company experience, Greg Gould is expected to play a pivotal role in driving the company's growth strategy and optimizing shareholder value. His wealth of expertise in capital management, profitability enhancement, and operational scaling will be vital as Aclarion continues to innovate its offerings.

About Greg Gould's Background

Greg Gould has a proven track record in the financial sector, having successfully raised over $450 million in public company debt and equity. His experience includes leading more than ten acquisitions and guiding three companies through uplistings to the Nasdaq. Before joining Aclarion, he served as CFO for several publicly-traded companies, most recently at Nanos Health, where he helped pave the way for innovative drug delivery systems.

Impact on Aclarion’s Vision

Brent Ness, the CEO of Aclarion, expressed enthusiasm about Gould's appointment, emphasizing his deep financial expertise. "Greg's background in public companies and capital strategies will significantly contribute to our mission of making Nociscan widely available to physicians dealing with chronic low back pain," said Ness. This enthusiasm reflects the company's commitment to improving patient experiences through innovative technology.

Aclarion’s Innovative Solutions

The key offering from Aclarion, Nociscan, represents a breakthrough in pain management technology. It is the first evidence-supported platform that noninvasively assists physicians in distinguishing between painful and nonpainful spinal discs. Nociscan utilizes advanced biomarkers and AI-driven algorithms to help analyze chemical signals associated with disc pain, thus allowing for more informed surgical decisions and better treatment outcomes.

Addressing a Global Health Challenge

Chronic low back pain (cLBP) is a pressing global health issue, affecting approximately 266 million individuals globally. Aclarion aims to alleviate this widespread condition by providing healthcare practitioners with tools that enhance clinical decision-making. The company is poised to make significant strides in treating cLBP through its innovative technologies and strategies.

Contact Information for Aclarion

For further inquiries about Aclarion's initiatives or to learn more about its groundbreaking technologies, individuals can reach out directly to the company. Aclarion encourages anyone interested in their products or opportunities to connect via email at info@aclarion.com.

Conclusion and Future Outlook

Aclarion's successful hiring of Greg Gould heralds a new chapter for the company, highlighting its commitment to growth and operational excellence. With a strong leadership team in place, Aclarion is well-prepared to enhance its market position and improve healthcare outcomes in the realm of chronic low back pain management.

Frequently Asked Questions

What is Nociscan?

Nociscan is Aclarion's innovative platform that helps physicians distinguish between painful and non-painful spinal discs using biomarkers and AI algorithms.

Who is Greg Gould?

Greg Gould is the newly appointed CFO of Aclarion, bringing extensive experience from his previous roles in public and private companies.

What challenges does chronic low back pain present?

Chronic low back pain is a significant healthcare challenge affecting millions of individuals, often leading to debilitating conditions and reduced quality of life.

How does Aclarion contribute to the healthcare industry?

Aclarion leverages advanced technologies and strategies to optimize treatments and improve patient outcomes in the healthcare sector.

How can individuals contact Aclarion?

Individuals can reach Aclarion by emailing their information inquiries to info@aclarion.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Dr. Kumar Joins Florida Cancer Specialists Team

Updated Category News Views 47

Welcoming a New Oncology Specialist to Bradenton What does a small but mighty addition mean for cancer care in Bradenton, Florida? Well, it feels like a big win for the locals. Dr. Vinod Kumar is the latest name to join the ranks of the Florida Cancer Specialists & Research Institute (FCS) at the Bradenton Cancer Center. With years under his belt in medical oncology and...

Continue Reading
Medtronic's Bold Move to Own Carotid Market Full-Scale

Updated Category News Views 64

When a giant like Medtronic makes a move, you can bet investors take notice, and this latest acquisition is no exception. They’re reaching into their deep pockets to acquire Contego Medical, a company shaking up the world of carotid artery disease treatments. It’s a tactical strike to solidify their leadership in cardiovascular solutions. Medtronic's Bet on Innovation...

Continue Reading
Main Capital Partners Backs TaskRay: Salesforce Expansion

Updated Category News Views 18

Investing in Transformation Main Capital Partners has thrown in with TaskRay, joining hands with Cloud Coach and JustOn to shake up customer delivery on Salesforce. These three are cooking up an ambitious AI-driven platform that's gunning to streamline from project management to financial operations. Main's stepping into this mix with a mindset that aligns with over 800...

Continue Reading
Waterfall Backs $48M Loan for Disney-area Hotel Upgrade

Updated Category News Views 15

A $48 Million Shot in the Arm for Portofino Inn Old-school Anaheim just got a real estate shake-up. Waterfall Asset Management's decision to lend a hefty $48 million to Dynamic City Capital (DCC) is more than just a financial move—it's a bet on tourism's bedrock, Disneyland. They're sinking this cash into the Portofino Inn & Suites, located a stone's throw from the...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 398

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Caladan Partners with Anchorage for Stronger Trading

Updated Category News Views 35

Caladan and Anchorage Unite for Asset Growth Man, partnerships might just be the secret sauce we never know we need until it’s on our plate. It's a fresh day in digital trading, and Caladan just shook things up by teaming up with Anchorage Digital, bolstering their trading and settlement capabilities to satisfy the big players. If there's one thing that's hot as a...

Continue Reading
ICCSD in Beijing: AI and Culture's Future Explored

Updated Category News Views 136

AI's Intersection with Culture in the Spotlight Imagine a room full of people hammering out the future of AI and culture—it starts to feel like a melting pot for the mind. That was the scene in Beijing when the ICCSD Advisory Committee congregated on October 26, 2026. With experts pooling from four different countries, there was no shortage of fireworks. They hashed out...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 109

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Bacterial Breakthrough in Cancer Therapy: Game Changer?

Updated Category News Views 0

Blurring Lines Between Bugs and Biotech Well, wouldn't you know it, the eggheads over at Jeonbuk National University in South Korea are at it again, pushing the boundaries of what these little bacterial buggers can do. This time, they’ve had a crack at cancer therapy, using engineered Salmonella to pack a double punch against breast cancer in mice. Now, if that ain't...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 307

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading

Top 5 Most Recently Viewed Articles

Future of Super Abrasives in Precision Engineering Markets

Updated Category News Views 96

Projected Growth of the Super Abrasives Market The global super abrasives market is on an exceptional growth trajectory, aiming to surpass a valuation of US$ 11.0 billion by 2032 from US$ 7.0 billion in 2023. This impressive growth, forecasted at an estimated CAGR of 6.5% from 2024 to 2032, reflects the diverse opportunities that lie ahead. Industry Drivers and...

Continue Reading
PSE&G Gains Top Spot in JD Power Rankings: What's Behind the Success?

Updated Category News Views 236

PSE&G Climbs To Number One Spot: What's Changed? Public Service Electric & Gas (PSE&G), New Jersey's largest utility, just snagged the top spot for business electric customer satisfaction in the East, according to JD Power's latest study. This is an upgrade from their second place showing in 2025. But how did they leapfrog their competition to reach the pinnacle? The...

Continue Reading
Hilbert Group Enhances Portfolio with Investment in CCD Token

Updated Category News Views 160

Hilbert Group Broadens Its Horizon with Strategic Investment Hilbert Group, a renowned global digital asset investment firm, is making waves in the blockchain space with its latest strategic long-term investment in CCD, the native token of Concordium, a cutting-edge PayFi blockchain designed for institutional-grade payments. A Landmark Move Beyond Bitcoin and Ethereum...

Continue Reading
Explore the Dynamic Features of the 2026 Ford Escape Now

Updated Category News Views 272

Discover the Exciting Evolution of the 2026 Ford Escape The all-new 2026 Ford Escape brings significant improvements in design, technology, and performance that will surely captivate new car buyers. Akins Ford, a premier Ford dealership near Atlanta, is excited to offer an in-depth look at what makes this compact SUV a standout choice for drivers. Key Design Enhancements...

Continue Reading
Forestar Group Navigates Challenges as Stock Hits New Low

Updated Category News Views 117

Forestar Group’s Stock Hits a 52-Week Low Forestar Group Inc. (NYSE: FOR) is experiencing a tough time in the current market environment. The company's shares have recently fallen to a 52-week low of $25.27. This decline highlights the struggles faced by the real estate and land development sector over the past year, contributing to a substantial 24.6% decrease in their...

Continue Reading